Stryker Photon Blade 3 Outcomes
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07930806. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Clinical Outcomes and Patient Satisfaction Following Lumpectomy Using the Photon Blade 3 Illuminated Electrosurgical Device With Integrated Smoke Evacuation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The PhotonBlade 3 Smoke Evacuation device is a monopolar RF device coupled with illumination that is FDA approved and indicated for cutting and coagulation of soft tissue during surgical procedures and for removing smoke generated by electrosurgery when used in conjunction with an effective smoke evacuation system. The device includes a coated electrode at the distal end of a rotatable and extendable shaft (telescope) which delivers monopolar radiofrequency energy for cutting and coagulation of tissue. These devices enable the operator to remotely conduct an electrosurgical current from the output connector of an electrosurgical unit (ESU) to the operative site for the desired surgical effect. The integrated LED-based illumination allows the user to turn on or off the illumination. The integrated smoke evacuation tubing enables the user to evacuate smoke generated by electrosurgery when used in conjunction with an effective smoke evacuation system. The Photon Blade 3 integrates localized surgical field illumination, simultaneous electrosurgical dissection, and active smoke evacuation. By improving visualization at the point of dissection and reducing smoke plume accumulation, surgeons perform more precise tissue dissection and hemostasis. The Photon Blade 3 device is FDA approved and being used in standard clinical care at Cleveland Clinic per its intended use. Utilization of the Photon Blade 3 expands feasibility of hidden scar lumpectomy approaches without compromising tissue handling. Cosmetic outcome after lumpectomy significantly influences patient satisfaction, body image, and quality of life. Reduced tissue trauma, optimized hemostasis, and improved control of the resection cavity translate into preservation of native breast contour, potentially leading to lower incidence of fat necrosis with less thermal injury, and more discrete scar placement. The overall goal of this study is to assess the clinical performance and safety of the Photon Blade 3 illuminated electrosurgical device with integrated smoke evacuation, including patient reported outcomes, incorporation of oncoplastic techniques, and surgical field optimization. This study allows for the collection of data from cases where the device is already being used in standard clinical care in accordance with its FDA approved indication.
Study identification
- NCT ID
- NCT07930806
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2026 (Estimated)
- Primary completion
- Oct 2027 (Estimated)
- Completion
- Oct 2027 (Estimated)
- Last update posted
- Nov 12, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07930806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.